Mundipharma is an innovative South African pharmaceutical company specialising in pain management. Our expertise and experience is, however, not limited to pain alone. Our goal is to help improve patients’ quality of life in whatever capacity we can. We are also actively engaged in the consumer health market with our range of over-the-counter products. Recently, we expanded into the ophthalmology therapeutic area with a range of acquired products.
Mundipharma South Africa started operations in September 2011 and has been growing steadily since then. Our head office is based in Cape Town but we have a national presence across South Africa. We also operate in Botswana, Lesotho, Namibia and Swaziland.
Our entrepreneurial spirit keeps us responsive to market opportunities and drives commercial success. Thanks to our lean, flat organisational structure, our employees feel empowered to make decisions, and take a personal pride in our success.
Mundipharma is a member of IPASA, the Innovative Pharmaceutical Association of South Africa, which represents pharmaceutical companies dedicated to bringing innovation and quality products to the South African pharmaceutical market.
Our deep understanding of patient and customer needs drives us to continually pursue innovative new partnerships and opportunities. We are part of a broader network of independent associated companies that have a presence in 48 countries worldwide - the United States of America, Canada, Australia and across Europe (including the United Kingdom, Germany, France and Spain), Asia, Africa and South America. This international reach and co-operation is an asset to us and our partners.